First clinical trial launches for a therapeutic vaccine targeting chronic hepatitis B, aiming to boost immune response and ...

The hepatitis B antigen protein comes in three versions: a small version, a medium version, and a large version. All three can be found in the protein coat surrounding the hepatitis D virus genome ...

In cases of human infection, hepatitis D is usually carried in by hepatitis B virus. The latter lends hepatitis D a protective coat replete with surface proteins, which enable entry into host cells.

Researchers at Princeton have determined how five cellular proteins contribute to an essential step in the life cycle of hepatitis B virus (HBV). The article describing these findings appeared ...

Hepatitis B virus, a killer of more than one million people each year, is a notoriously wily virus, often lingering and ...

A UNSW researcher studying the history of hepatitis B treatment uncovers the prehistory of COVID-19's famous RAT and PCR tests – and an Australian ...

Scientists report that a class of drugs, called RNA interference (RNAi) therapeutics, represent a major advancement in the ...

The research team determined that in order for protein X to get made, the hepatitis B virus’s DNA needs to get organized into DNA-histone complexes called nucleosomes. “… we generated ...

Tiny, dangerous, and easily transmitted, hepatitis B virus (HBV) chronically affects about 296 million people and kills about 1 million every year. This stealthy virus invades the liver and ...

TherVacB, a therapeutic vaccine for chronic hepatitis B, has entered its first clinical trial in patients. The first patient ...